The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

Delphine S. Courvoisier, Katarina Chatzidionysiou, Denis Mongin, Kim Lauper, Xavier Mariette, Jacques Morel, Jacques-Eric Gottenberg, Sytske Anne Bergstra, Manuel Pombo Suarez, Catalin Codreanu, Tore K. Kvien, Maria Jose Santos, Karel Pavelka, Merete L. Hetland, Johan Askling, Carl Turesson, Satoshi Kubo, Yoshiya Tanaka, Florenzo Iannone, Denis ChoquetteDan C. Nordström, Ziga Rotar, Galina Lukina, Cem Gabay, Ronald Van Vollenhoven, Axel Finckh

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalRheumatology
Volume60
Issue number2
Pages (from-to)820-828
Number of pages9
ISSN1462-0324
DOIs
Publication statusPublished - Feb 2021
MoE publication typeA1 Journal article-refereed

Fields of Science

  • rheumatoid arthritis
  • seropositivity
  • anti-citrullinated protein antibodies
  • ACPA
  • rheumatoid factor
  • drug retention
  • TOCERRA
  • PANABA
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this